Her anemia resolved, but her thrombocytopenia persisted and remained largely refractory to multiple first-line treatments, including intravenous immunoglobulin therapy, steroids, and thrombopoietin receptor agonists. This evidence concerns the gene MPL and Thrombocytopenia.